Are there clinically relevant differences between the fixed ratio, combination regimens-- iGlarLixi or iDegLira--consisting of a long-acting insulin and GLP-1 RA?

Are there clinically relevant differences between the fixed ratio, combination regimens-- iGlarLixi or iDegLira--consisting of a long-acting insulin and GLP-1 RA?

Are there clinically relevant differences between the fixed ratio, combination regimens— iGlarLixi or iDegLira— consisting of a long-acting insulin and GLP-1 RA?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Robert Henry, MD

Robert Henry, MD

Chief, Center for Metabolic Research Chief, Section of Endocrinology, Metabolism & Diabetes Veterans Affairs Healthcare System Professor of Medicine‚ Department of Medicine Division of Endocrinology and Metabolism University of California‚ San Diego